Margaret Moses Branch is an attorney and partner at Branch Law Firm in Albuquerque, New Mexico. She represents clients in medical malpractice, personal injury, mass torts, toxic torts, products liability, and general litigation matters. Admitted to practice in New Mexico and Colorado, she is also admitted to the U.S. Court of Appeals for the Tenth Circuit and the U.S. District Court for the District of New Mexico. Margaret earned her J.D. and B.S. from the University of New Mexico.
LATEST ARTICLES BY: Margaret Moses Branch
Senate To Begin Investigation Of DePuy Hip Safety
|
|
Last Modified
on
May 02, 2024
This week the U.S Senate will begin its probe into medical device recalls and the connection between the massive DePuy Hip Replacement recall and the FDA’s role in “protecting patient safety as part of the medical device approval process.” The DePuy Hip was recalled after numerous reports of metal shards breaking off the hip replacement… read more
Zimmer NexGen Knee Recall Urged Due To Component Problems
|
|
Last Modified
on
May 02, 2024
Several physicians are urging a Zimmer NexGen Knee recall as the result of serious problems and component failures in the knee, requiring additional surgeries. The FDA has recalled some of the components following several lawsuits concerning the Zimmer NexGen CR-Flex knee failure rate. In fact, a prominent consultant for Zimmer recently went public stating that… read more
FDA Removes 500 Unapproved Prescription Drugs From The Market
|
|
Last Modified
on
May 02, 2024
The FDA has announced that it will be seeking to remove nearly 500 unapproved prescription drugs from the market. In a statement, the director of compliance at the Center for Drug Evaluation and Research notes that they “don’t know what’s in them, whether they work properly, or how they are made.” If believe you may… read more
Topamax Linked To Birth Defects
|
|
Last Modified
on
Mar 16, 2024
The New York Times reports that Topamax, manufactured by Johnson & Johnson, has been linked to birth defects, such as a higher risk of developing cleft lips and palates, genital malformations, and cranial malformations. Topamax is an anti-seizure and migraine drug used in the treatment of migraines and epilepsy. It is also used in the… read more
Medical Malpractice Reform Should Focus On Patient Safety
|
|
Last Modified
on
May 02, 2024
Medical Malpractice reform has been receiving much attention recently with the introduction of H.R. 5, which seeks to impose national tort reform measures, including the imposition of caps on non-economic damages as well as potentially taking away the right to trial by jury in some medical malpractice cases. As New Mexico medical malpractice lawyers, we… read more
New Mexico Corporation Settles Nursing Home Negligence Case For $3.5 Million
|
|
Last Modified
on
Mar 16, 2024
A recent news report indicates that a New Mexico Corporation, Sunbridge Health Court Corp., has reached a settlement in a nursing home negligence case for $3.5 million. If you believe a loved one has suffered from nursing home abuse, you need an experienced Albuquerque nursing home abuse lawyer. The lawsuit was filed in 2009 alleging… read more
Product Liability Claims Arising Out Of DePuy Hip Replacements
|
|
Last Modified
on
May 02, 2024
As reported in the Wall Street Journal – as the result of a loophole in the Food and Drug Administration’s regulation of medical implants – many potentially faulty hip implants are on the market. New drugs must undergo clinical trials before receiving FDA approval, however, if a medical implant resembles a product already on the… read more
Supreme Court Agrees To Hear Generic Reglan Drug Label Suit
|
|
Last Modified
on
Mar 16, 2024
The U.S. Supreme Court has agreed to hear arguments over whether generic drug makers can be sued for the failure to warn about dangerous side effects on their drug label even when they follow federal rules. In PLIVA, Inc. v. Mensing a woman took metoclopramide – the generic equivalent of Reglan – for four years… read more
American Dangerous Drug Trials Being Conducted Overseas
|
|
Last Modified
on
Mar 16, 2024
A recent investigative article has disclosed some scary statistics. Even with FDA approval, prescription drugs kill nearly 200,000 Americans each year. As a result of consumer backlash and the raised awareness of the potential risks of dangerous drugs such as Avandia, Reglan, and Darvon/Darvocet, many U.S. drug companies have now moved their clinical trials overseas… read more
Darvon/Darvocet Pulled From The Market
|
|
Last Modified
on
Mar 16, 2024
Last week, the FDA finally pulled propoxyphene – sold as Darvon and Darvocet – from the U.S. market. For nearly 50 years concerns have been raised over the side effects of Darvon/Darvocet usage, including its toxicity even at low levels and its highly addictive properties. Additionally, it has not been shown to be very effective… read more
